Phosphatidylinositide 3-kinase inhibition: A new potential target for the treatment of polycystic ovarian syndrome

Phosphatidylinositide-3 Kinase: A Newer Molecular Target in Metabolic and Hormonal Pathway of Polycystic Ovary Syndrome

(2014) K. Shah et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Unilateral or bilateral vagotomy induces ovulation in both ovaries of rats with polycystic ovarian syndrome

(2013) Rosa Linares et al.   Reproductive Biology and Endocrinology

In –silico molecular docking analysis of prodigiosin and cycloprodigiosin as COX-2 inhibitors

(2013) Pabba Shiva Krishna et al.   SpringerPlus

The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?

(2012) Andrew Lansdown et al.   CLINICAL ENDOCRINOLOGY

Trace glucose and lipid metabolism in high androgen and high-fat diet induced polycystic ovary syndrome rats

(2012) Hua-Ling Zhai et al.   Reproductive Biology and Endocrinology

Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats

(2012) Fang Wang et al.   Journal of Ovarian Research

The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS)

(2012) Aylin Yaba et al.   Journal of Ovarian Research

Luteinizing hormone-induced Akt phosphorylation and androgen production are modulated by MAP Kinase in bovine theca cells

(2009) Shin Fukuda et al.   Journal of Ovarian Research

Both Intestinal and Hepatic Lipoprotein Production Are Stimulated by an Acute Elevation of Plasma Free Fatty Acids in Humans

(2008) Hélène Duez et al.   CIRCULATION

Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome

(2008) T. M. Barber et al.   DIABETOLOGIA